國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Acute myeloid leukemia

Ossenkoppele, Gert J.

Acute myeloid leukemia

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Acute myeloid leukemiaedited by Christoph Rollig, Gert J. Ossenkoppele.
其他作者:	Rollig, Christoph.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	viii, 358 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Acute myeloid leukemia.
電子資源:	https://doi.org/10.1007/978-3-030-72676-8
ISBN:	9783030726768$q(electronic bk.)

Acute myeloid leukemia
Acute myeloid leukemia[electronic resource] /edited by Christoph Rollig, Gert J. Ossenkoppele. - Cham :Springer International Publishing :2021. - viii, 358 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

1. Epidemiology and Etiology -- 2. Diagnosis and Classification of AML: WHO 2016 -- 3. The Genomic Landscape and Clonal Evolution of AML -- 4. Clinical Manifestation and Diagnostic Workup -- 5. Prognostic Factors and Treatment Allocation -- 6. Treatment of Acute Promyelocytic Leukemia -- 7. Treatment of Newly Diagnosed AML in FitPatients -- 8. Treatment of Newly Diagnosed AML in Unfit Patients -- 9. Treatment of Relapsed and Refractory AML -- 10. Allogeneic Stem Cell Transplantation -- 11. Special Clinical Scenarios -- 12. Future Developments.

This book, written by a team of leading experts, provides a comprehensive overview of acute myeloid leukemia (AML), the most frequent acute leukemia in adults. The opening chapters present current knowledge of epidemiology, etiologic factors, and the pathogenesis and molecular development of AML. Detailed guidance is offered on laboratory and clinical diagnostic workup and disease classification, and the patient- and disease-related factors that determine prognosis and treatment allocation are identified. On the basis of these general considerations, initial treatments in patients considered fit for intensive treatment and in older and co-morbid patients are reviewed, and the available relapse treatment strategies, explained. For all clinical scenarios, the most recent data on the optimal use of newly approved agents in different AML subgroups are presented. Separate chapters address the treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for innovative trial designs are considered.

ISBN: 9783030726768$q(electronic bk.)

Standard No.: 10.1007/978-3-030-72676-8doiSubjects--Topical Terms:

486257
Acute myeloid leukemia.

LC Class. No.: RC643 / .A38 2021

Dewey Class. No.: 616.99419

Acute myeloid leukemia
LDR:02804nmm a2200337 a 4500 001 598835
003 DE-He213
005 20210518092330.0
006 m d
007 cr nn 008maaau
008 211025s2021 sz s 0 eng d
020 $a 9783030726768$q(electronic bk.)
020 $a 9783030726751$q(paper)
024 7 $a 10.1007/978-3-030-72676-8 $2 doi
035 $a 978-3-030-72676-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC643 $b .A38 2021
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.99419 $2 23
090 $a RC643 $b .A189 2021
245 0 0 $a Acute myeloid leukemia $h [electronic resource] / $c edited by Christoph Rollig, Gert J. Ossenkoppele.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 358 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
505 0 $a 1. Epidemiology and Etiology -- 2. Diagnosis and Classification of AML: WHO 2016 -- 3. The Genomic Landscape and Clonal Evolution of AML -- 4. Clinical Manifestation and Diagnostic Workup -- 5. Prognostic Factors and Treatment Allocation -- 6. Treatment of Acute Promyelocytic Leukemia -- 7. Treatment of Newly Diagnosed AML in FitPatients -- 8. Treatment of Newly Diagnosed AML in Unfit Patients -- 9. Treatment of Relapsed and Refractory AML -- 10. Allogeneic Stem Cell Transplantation -- 11. Special Clinical Scenarios -- 12. Future Developments.
520 $a This book, written by a team of leading experts, provides a comprehensive overview of acute myeloid leukemia (AML), the most frequent acute leukemia in adults. The opening chapters present current knowledge of epidemiology, etiologic factors, and the pathogenesis and molecular development of AML. Detailed guidance is offered on laboratory and clinical diagnostic workup and disease classification, and the patient- and disease-related factors that determine prognosis and treatment allocation are identified. On the basis of these general considerations, initial treatments in patients considered fit for intensive treatment and in older and co-morbid patients are reviewed, and the available relapse treatment strategies, explained. For all clinical scenarios, the most recent data on the optimal use of newly approved agents in different AML subgroups are presented. Separate chapters address the treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for innovative trial designs are considered.
650 0 $a Acute myeloid leukemia. $3 486257
650 1 4 $a Hematology. $3 274899
700 1 $a Rollig, Christoph. $3 892735
700 1 $a Ossenkoppele, Gert J. $3 892736
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Hematologic malignancies. $3 560151
856 4 0 $u https://doi.org/10.1007/978-3-030-72676-8
950 $a Medicine (SpringerNature-11650)